Higher Doses: Doses up to 4000 mg/day were studied but did not consistently show additional benefits over 2000 mg/day
Reducing glutathione production in lymphoma cells, either through pharmacological inhibition of glutamate cysteine ligase (GCL), the enzyme catalyzing the rate-limiting step in glutathione biosynthesis, or via knockdown of GCLC , the GCL catalytic subunit, sharply decreased cell growth in 3D gels and xenografts
BPC/TB-500 BPC-157 / TB-500 5mg/5mg (Wolverine Stack) is a research-grade peptide blend formulated for laboratory investigations involving peptide signaling, angiogenesis, extracellular matrix biology, cytoskeletal organization, and cellular communication
Always consult your healthcare team before making any changes to your medication regimen, as they can provide personalised guidance based on your specific health conditions and needs